WO2009132727A1 - On-line quantitative analysis method of the content of antiscalant compounds containing phosphorous in sea water in a reverse osmosis desalination plant and corresponding control method and equipment - Google Patents
On-line quantitative analysis method of the content of antiscalant compounds containing phosphorous in sea water in a reverse osmosis desalination plant and corresponding control method and equipment Download PDFInfo
- Publication number
- WO2009132727A1 WO2009132727A1 PCT/EP2009/001406 EP2009001406W WO2009132727A1 WO 2009132727 A1 WO2009132727 A1 WO 2009132727A1 EP 2009001406 W EP2009001406 W EP 2009001406W WO 2009132727 A1 WO2009132727 A1 WO 2009132727A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- acid
- sea water
- salts
- antiscalant
- dilution
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 61
- 238000000034 method Methods 0.000 title claims abstract description 52
- 239000013535 sea water Substances 0.000 title claims abstract description 39
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 238000001223 reverse osmosis Methods 0.000 title claims abstract description 27
- 238000010612 desalination reaction Methods 0.000 title claims abstract description 16
- 238000004445 quantitative analysis Methods 0.000 title claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 53
- 238000010790 dilution Methods 0.000 claims abstract description 33
- 239000012895 dilution Substances 0.000 claims abstract description 33
- 238000004458 analytical method Methods 0.000 claims abstract description 29
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 19
- 239000002253 acid Substances 0.000 claims description 38
- 150000003839 salts Chemical class 0.000 claims description 33
- 230000003750 conditioning effect Effects 0.000 claims description 14
- 230000001276 controlling effect Effects 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
- 230000029087 digestion Effects 0.000 claims description 10
- 229920000388 Polyphosphate Polymers 0.000 claims description 6
- 238000004737 colorimetric analysis Methods 0.000 claims description 6
- 239000001205 polyphosphate Substances 0.000 claims description 6
- 235000011176 polyphosphates Nutrition 0.000 claims description 6
- 235000010323 ascorbic acid Nutrition 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 5
- 239000011668 ascorbic acid Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- -1 hexamethylen Chemical class 0.000 claims description 4
- 230000007062 hydrolysis Effects 0.000 claims description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 4
- ZJAOAACCNHFJAH-UHFFFAOYSA-N phosphonoformic acid Chemical compound OC(=O)P(O)(O)=O ZJAOAACCNHFJAH-UHFFFAOYSA-N 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 125000005461 organic phosphorous group Chemical group 0.000 claims description 3
- MEUIIHOXOWVKNP-UHFFFAOYSA-N phosphanylformic acid Chemical compound OC(P)=O MEUIIHOXOWVKNP-UHFFFAOYSA-N 0.000 claims description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims description 2
- 229920000805 Polyaspartic acid Polymers 0.000 claims description 2
- 229920002125 Sokalan® Polymers 0.000 claims description 2
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 claims description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 2
- 230000015556 catabolic process Effects 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 238000006731 degradation reaction Methods 0.000 claims description 2
- XQRLCLUYWUNEEH-UHFFFAOYSA-N diphosphonic acid Chemical compound OP(=O)OP(O)=O XQRLCLUYWUNEEH-UHFFFAOYSA-N 0.000 claims description 2
- 229960005102 foscarnet Drugs 0.000 claims description 2
- 229920001519 homopolymer Polymers 0.000 claims description 2
- ZODDGFAZWTZOSI-UHFFFAOYSA-N nitric acid;sulfuric acid Chemical compound O[N+]([O-])=O.OS(O)(=O)=O ZODDGFAZWTZOSI-UHFFFAOYSA-N 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 125000005385 peroxodisulfate group Chemical group 0.000 claims description 2
- 150000003009 phosphonic acids Chemical class 0.000 claims description 2
- 239000004584 polyacrylic acid Substances 0.000 claims description 2
- 108010064470 polyaspartate Proteins 0.000 claims description 2
- 229920001444 polymaleic acid Polymers 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 239000001119 stannous chloride Substances 0.000 claims description 2
- 235000011150 stannous chloride Nutrition 0.000 claims description 2
- 229920001897 terpolymer Polymers 0.000 claims description 2
- ZTWTYVWXUKTLCP-UHFFFAOYSA-N vinylphosphonic acid Chemical compound OP(O)(=O)C=C ZTWTYVWXUKTLCP-UHFFFAOYSA-N 0.000 claims description 2
- NLVXSWCKKBEXTG-UHFFFAOYSA-N vinylsulfonic acid Chemical compound OS(=O)(=O)C=C NLVXSWCKKBEXTG-UHFFFAOYSA-N 0.000 claims description 2
- 150000001735 carboxylic acids Chemical class 0.000 claims 1
- DKPHLYCEFBDQKM-UHFFFAOYSA-H hexapotassium;1-phosphonato-n,n-bis(phosphonatomethyl)methanamine Chemical compound [K+].[K+].[K+].[K+].[K+].[K+].[O-]P([O-])(=O)CN(CP([O-])([O-])=O)CP([O-])([O-])=O DKPHLYCEFBDQKM-UHFFFAOYSA-H 0.000 claims 1
- 230000003647 oxidation Effects 0.000 claims 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 claims 1
- 150000002500 ions Chemical class 0.000 abstract description 3
- 239000012528 membrane Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 8
- 239000008400 supply water Substances 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000005755 formation reaction Methods 0.000 description 7
- 239000003112 inhibitor Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 3
- 230000002572 peristaltic effect Effects 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000700 radioactive tracer Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 2
- 229910001634 calcium fluoride Inorganic materials 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 239000002455 scale inhibitor Substances 0.000 description 2
- 150000004760 silicates Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052925 anhydrite Inorganic materials 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001175 calcium sulphate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910052923 celestite Inorganic materials 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000009996 mechanical pre-treatment Methods 0.000 description 1
- 150000002735 metacrylic acids Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/02—Reverse osmosis; Hyperfiltration ; Nanofiltration
- B01D61/12—Controlling or regulating
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
- C02F1/441—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis by reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/08—Seawater, e.g. for desalination
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/005—Processes using a programmable logic controller [PLC]
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2209/00—Controlling or monitoring parameters in water treatment
- C02F2209/18—PO4-P
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A20/00—Water conservation; Efficient water supply; Efficient water use
- Y02A20/124—Water desalination
- Y02A20/131—Reverse-osmosis
Definitions
- the invention relates to an on-line quantitative analysis method of the content of antiscalant compounds containing phosphorous in sea water in a reverse osmosis desalination plant.
- the invention also relates to a method for controlling a reverse osmosis sea water desalination plant, where the plant has means for adding antiscalant compounds containing phosphorous at a sea water inlet flow and means for regulating and controlling the addition means.
- the invention also relates to equipment for controlling a reverse osmosis sea water desalination plant.
- Metals iron, manganese, aluminium
- Organic material coagulants, humic acids, oils and grease
- the aim of the invention is to overcome these drawbacks. This purpose is achieved by means of an analysis method of the type indicated at the beginning and characterized in that it comprises the following stages :
- stage [c] includes a first part, or substage, wherein the antiscalant compounds containing phosphorous that are present in the diluted water are subject to a chemical treatment in which they become orthophosphates.
- the chemical treatment is hydrolysis.
- the phosphorous concentration can be determined thanks to s the antiscalant compounds.
- the dilution water has a conductivity reading of less than 1,000 ⁇ S/cm, preferably less than 400 ⁇ S/cm.
- a single stage of reverse osmosis is used to desalinate sea water. In other applications, normally two stages are used0 to obtain a better quality (in other words, less conductivity).
- the conductivity of the water product or permeated water is usually between 700-100 microsiemens/cm. This permeated water is preferably the one that will be used for diluting, although any other water source could be used.
- the antiscalant compounds containing phosphorous comprise at least one compound from the group made up of organophosphorated compounds, polyphosphates, phosphinocarboxylic acid and mixtures thereof.
- these compounds are also mixed with other compounds, such as for example polycarboxylic acids and/or the salts thereof, wherein it is particularly advantageous that the polycarboxylic acid be a compound from the group made up of homopolymers derived from polyacrylic acid, polymethacrylic acid, polymaleic acid and polyaspartic acid, copolymers and terpolymers of acrylic acid, metacrylic acid, maleic acid, vinylsulphonic acid, alkylsulphonic acid, metalylsulphonic acid, 2- acrylamide-2-metyl-i-propansulphonic acid, vinylphosphonic acid and acryalamide.
- the organophosphorated compounds are organophosphonated compounds, and very preferably they are phosphonic acids and the derived salts thereof (phosphonates).
- the organophosphonated compounds be compounds from the group made up of phosphonocarboxylic acid, ethylendiaminotetra(methylenphosphonic) acid and the salts thereof, hexamethylendiaminotetra(methylenphosphonic) acid and the salts thereof, diethylentriaminopenta(methylen ⁇ hosphonic) acid and the salts thereof, aminotrt(methylenphosphonic) acid and the salts thereof, 1-hydroxylethyliden(1 ,1-diphosphonic) acid and the salts thereof, 2-phosphonobutane-1,2,4-tricarboxylic acid and the salts thereof, morpholinometane diphosphonic acid and the salts thereof, ethanol aminobismethylenphosphonic acid and the salts thereof, ethylentriaminopentakis(methylenphosphonic) acid and the salts thereof, bis(hexamethylen)triaminopenta-(rnethylenphosphonic) acid and the salts
- the dilution stage is carried out in a conditioning tank and comprises stirring performed with stirring means.
- the orthophosphate concentration analysis stage is carried out using a colorimetric method.
- the analysis stage of the total phosphorous content comprises a substage wherein the polyphosphates and/or compounds containing organic phosphorous are hydrolysed into orthophosphates, and, advantageously, a substage wherein the orthophosphate analysis is performed using a colorimetric method.
- the hydrolysis is preferably carried out using a method from the group made up of digestion with perchloric acid, oxydation with peroxodisulphate, digestion with nitric acid - sulphuric acid and oxydative degradation by ultraviolet radiation.
- the cotormetric method is preferably a method from the group made up of the colorimetric method of vanadomolibdophosphoric acid, the stannous chloride method and the ascorbic acid method.
- the aim of the invention is also a method for controlling a reverse osmosis sea water desalination plant, where the plant has means for adding antiscalant compounds containing phosphorous at a sea water inlet flow and means for regulating and controlling the addition means, characterized in that an analysis method according to the invention is performed on said salt water inlet flow and the result of said quantitative analysis is sent to said regulation and control means.
- the analysis method according to the invention provides obtainable results in a very short space of time (in a few minutes), which means that a quasi continuous control can be set up, which greatly reduces the risk of scale forming on the membranes since the amount of antiscalant compounds to be added can be modified almost in real time or, where applicable, the desalination process can be interrupted.
- Another aim of the invention is a piece of equipment for controlling a reverse osmosis sea water desalination plant, characterized in that it has dilution means and analysis means suitable for performing an analysis method according to the invention.
- Fig. 1 is an evolution graph, over time, of the concentration of an antiscalant compound containing phosphorous in a sea water current that supplies a reverse osmosis desalination plant, measured by means of control equipment according to the invention.
- the antiscalant compound is transported in concentrated format.
- the concentrated antiscalant compound used is a solution at 25.35% of ethylendiamine tetra(methylenphospho ⁇ ic acid) pentasodium salt.
- the concentrated antiscalant solution is diluted in a dilution tank before being metered continuously to the supply water.
- the concentrated antiscalant solution is diluted up to a concentration of 25% with water that has a conductivity reading of 168 microsiemens/cm.
- the antiscalant compound diluted in the previous stage is metered continuously at a flow rate of 0.024 millimetres per minute (mL/min) into the water supplied to the plant (which has an approximate flow rate of 4000 mUmin).
- the concentration of the antiscalant compound in the supply water is approximately 1.5 ppm (parts per million).
- the sea water that enters the plant has a conductivity reading of 46,890 microsiemens/cm.
- the metered inhibitor concentration in the sea water supplied to the osmosis plant is analysed continuously.
- the analysis comprises the following stages:
- sea water is pumped from the plant supply effluyent, after metering the antiscalant compound, to the sample conditioning tank.
- the sea water containing the antiscalant compound is metered into the conditioning tank by a pump at a flow rate of 9.7 mL/min.
- dilution water is metered into the conditioning tank, said dilution water having a conductivity reading of 168 microsiemens/cm, in order to dilute the sea water containing the antiscalant compound.
- the dilution water is added to the conditioning tank by a metering pump operating at a rate of 29.1 mL/min.
- the sea water containing the antiscalant compound and the dilution water are mixed in the conditioning tank using a stirrer.
- the sea water containing the antiscalant compound is diluted at a dilution factor of 4.
- the conductivity reading of the mixture is 10,930 microsiemens/cm.
- the time period during which the water remains in the conditioning tank is approximately 60 minutes.
- a sample is taken of the conditioning tank water and the orthophosphate content thereof is analysed.
- the conditioning tank water sample is fed into the digestion tub using a peristaltic pump.
- the ascorbic acid method is used to analyse the orthophosphate content. This method is based on the reaction of orthophosphate ions with an acid solution containing molibdate and antimonium ions to form the antimonyl- phosphomolibdate complex.
- the complex formed is reduced with ascorbic acid to produce a strongly coloured blue molibdene complex.
- the intensity of the blue colour is proportional to the orthophosphate concentration.
- the reagents are added to the tub containing the water sample using peristaltic pumps, the tub is shaken and when the reaction finishes the intensity of the blue colouring is measured, taking -into account the zero that has been determined shortly before, and which is considered as a measurement of the phosphate concentration expressed in milligrams per litre of phosphorous (mg/L P).
- a sample is taken of the conditioning tank water and the total phosphorous content is analysed.
- the conditioning tank water sample is fed into the digestion tub using a peristaltic pump.
- the polyphosphates and organophosphorated compounds and phosphinocarboxylic acids of the sample are hydrolyzed into orthophosphates via digestion by boiling in a strong acid solution. This is achieved by oxydating the phosphorous compounds with sodium peroxodisulphate in a strong acid solution.
- the sample is boiled and excess pressure is applied thereto to accelerate the process and this way, short digestion times are achieved.
- the orthophosphate analysis is carried out in the same tub.
- the ascorbic acid method is used, as explained above.
- the orthophosphate assessed this way is a measurement of the concentration of total phosphorous expressed in milligrams per litre of phosphorous (mg/L P).
- fd dilution of the sea water containing antiscalant compounds, which is performed in the conditioning tank. In the example, dilution 4 was performed.
- the results obtained in the example are shown in Figure 1.
- the abscissas axis represents the time expressed in minutes
- the ordenate axis represents the antiscalant compound concentration (solution at 25.35% of ethylendiamine tetra(methylenphosphonic acid) pentasodium salt) in the water supplied to the pilot reverse osmosis plant.
- the average antiscalant concentration during the assay period was 1.549 mg/L.
- the desired antiscalant concentration in the supply water was 1.5 mg/L.
- a very exact reading of the antiscalant concentration was obtained.
- the standard deviation of the concentrations measured was 1.229 % with respect to the average.
- stage [b] stage of analysing the orthophosphate concentration contained in the diluted water
- stage [c] stage of analysing the total phosphorous content contained in the diluted water
Landscapes
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Chemical & Material Sciences (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Organic Chemistry (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Abstract
On-line quantitative analysis method of the content of antiscalant compounds containing phosphorous in sea water in a reverse osmosis desalination plant and corresponding control method and control equipment. On-line quantitative analysis method of the contents of antiscalant compounds containing phosphorous in sea water in a reverse osmosis desalination plant, which comprises the following stages: [a] dilution of sea water until it obtains a conductivity reading of between 25,000 and 3,000 microsiemens/cm, [b] analysis of the concentration of orthophosphate. [c] analysis of the total phosphorous concentration. [d] determination of the concentration of said antiscalant compounds. The method provides a fast, on-line analysis of the water entering the desalination plant, which means said water can be controlled very accurately. Dilution prevents possible problems of crossed sensibility with the Na+ and Cl" ions contained in the sea water.
Description
ON-LINE QUANTITATIVE ANALYSIS METHOD OF THE CONTENT OF
ANTISCALANT COMPOUNDS CONTAINING PHOSPHOROUS IN SEA WATER IN
A REVERSE OSMOSIS DESALINATION PLANT AND CORRESPONDING
CONTROL METHOD AND EQUIPMENT
DESCRIPTION
Field of the invention
The invention relates to an on-line quantitative analysis method of the content of antiscalant compounds containing phosphorous in sea water in a reverse osmosis desalination plant. The invention also relates to a method for controlling a reverse osmosis sea water desalination plant, where the plant has means for adding antiscalant compounds containing phosphorous at a sea water inlet flow and means for regulating and controlling the addition means. The invention also relates to equipment for controlling a reverse osmosis sea water desalination plant.
State of the art
Using the reverse osmosis technique has limitations regarding the quality of the effluyents to be treated. The effectiveness of the reverse osmosis is limited because the membranes become soiled. The pre-treatment of reverse osmosis plants is designed so that the water supplied to the membranes has a low soiling potential, in terms of materials in suspension, particulated material, colloidal and microorganisms. Also it is necessary to foresee the formation of inorganic scale inside the membrane system. Therefore the water supplied has to be pre-treated appropriately. There are various pre-treatment techniques available that use chemical and/or mechanical treatments. The mechanical pre-treatment techniques used are: clarifiers, filters, active carbon filters, sand filters, cartridge filters, etc.
The most common substances in the supply water that soil the membrane are:
- Sediments and particles (clay, colloidal silica, silicates)
- Inorganic scale (calcium carbonate, calcium sulphate, barium and strontium, calcium fluoride, soluble silica)
Metals (iron, manganese, aluminium) - Organic material (coagulants, humic acids, oils and grease)
- . Micro-organisms and material of biological origin
To ensure that no precipitates or scale are formed, a complex analysis must be carried out. This will depend on the chemical composition of the supply water, the conversion percentage ("conversion" is understood to be the percentage of supply water that is converted into permeated water or product), the pH, and finally on the metering, or not, of products that inhibit the formation of scale (also known as antiscalant products). In reverse osmosis, the water concentrated in contact with the membrane is the one which can cause more scale problems. As the water circulates through the membrane, the ions in solution concentrate until they overcome the solubility of certain potentially scale forming salts, causing the formation of precipitates. Reverse osmosis cannot tolerate even the smallest precipitate, even if it is not visible, as it could seriously damage membrane permeability. The pure or permeated water obtained in the separation process cannot cause any problem because it lacks, or virtually lacks, any dissolved salts.
In the beginning when osmosis was used, operating conditions were sought where it was impossible for saline substances to precipitate and, therefore, for scale to form. On one hand, adding high quantities of acid increased the solubility of many potentially scale forming salts. On the other hand, by operating often at relatively low conversions, the saline concentration did not reach critical values.
At present, the implementation of the use of polyamide membranes that do not need acid to be added, because they do not suffer from hydrolysis problems in normal operating conditions, means systems can operate at conditions with a higher scale forming potential. Moreover, with greater water and energy rationalisation, systems operate at the highest conversions possible.
Under these operating conditions, the risk of scale is very high and if competitive plants are to be built, antiscalant additives must be metered accurately into the water supplied to the membrane system. These additives are an essential aid, and the metering thereof must be minimized (optimized), as operating under unnecessarily high concentrations causes unavoidable economic expenses.
Scale inhibitors, or antiscalant agents, used to prevent the formation of scale in the membrane systems are formulae based on molecules that delay the formation of the growth nuclei of the crystals and/or distort the crystalline structure of the scale. The inhibition of crystalline growth is considered to be the most effective method in controlling the formation of CaCO3, CaF2, CaSO4, BaSO4, SrSO4, Ca3(PO4J2, Mg(OH)2, MgCOe scale and silicates in the membrane system.
The control of the metering of antiscalant additives is very important. The lack of antiscalant treatment can render a plant useless, and although many times it is possible to perform a chemical cleaning process whereby it is possible to recover a large part of the permeability that has been lost, the cleaning is complex and time- consuming, and leaves the plant out of service. Therefore it is very important to ensure a certain concentration of inhibitants throughout the time that the reverse osmosis plant is operating, in order to fully protect the membrane system from the precipitation of insoluble compounds. An insufficient dosis, or interrupting the dosage, can result in a serious problem of scale formations on the membrane surface.
One of the usual methods for controlling the metering of the inhibitor is by frequently monitoring the consumption of antiscalant agent. One drawback of this control method is that the concentration of the scale inhibitor is not measured directly, online. Therefore, if there were a fault in the pump, or if the product drum were empty, the appropriate product concentration in the system for preventing the precipitation of the insoluble compounds would not be maintained.
Normally, inhibitor control cannot be performed quickly or in situ, as it involves time- consuming laboratory processes that require long analysis times. On-line inhibitor
- A -
follow-up systems exist wherein an easily measurable fluorescent tracer is used to quantify the level of chemical treatment present in the water supply, the permeated water and in the water concentrate. Nevertheless, using the fluorescent tracer is, at any event, an indirect measurement that can lead to errors because variations in the tracer content do not always correspond to real variations in the inhibitor. Also, it requires an additional compound to be added to the water, which can be significant depending on the subsequent use of the permeated water. No on-line analysis of the active inhibitor material is carried out at any time.
Disclosure of the invention
The aim of the invention is to overcome these drawbacks. This purpose is achieved by means of an analysis method of the type indicated at the beginning and characterized in that it comprises the following stages :
[a] dilution of sea water with dilution water to obtain diluted water, until the diluted water has a conductivity reading of between 25,000 and 3,000 microsiemeπs/cm,
[bj analysis of the concentration of orthophosphate contained in the diluted water,
[c] analysis of the total phosphorous concentration in the diluted water,
[d] determination of the concentration of said antiscalant compounds in the sea water, taking into account the difference between the total phosphorous and the orthophosphate, multiplying by a specific factor of the antiscalant compounds and multiplying by a factor related with the dilution.
In fact, the antiscalant compounds are not detected when analysing the orthophosphates in stage [b] and only appear in stage [c]. Therefore, preferably, stage [c] includes a first part, or substage, wherein the antiscalant compounds containing phosphorous that are present in the diluted water are subject to a chemical treatment in which they become orthophosphates. This way the same
orthophosphate analysing device can be used. Preferably the chemical treatment is hydrolysis.
Through differences, the phosphorous concentration can be determined thanks to s the antiscalant compounds.
Dilution stage [a] is particularly important as high conductivity interferes in the analysis. It must be taken into account that the conductivity values of the sea water vary between 35,000 and 70,000 microsiemens/cm. 0
Preferably, the dilution to be performed depends on the conductivity of the sea water that the inhibitor contains, and which supplies the reverse osmosis plant. The following table shows the dilution factor preferably applied to the dilution tank according to the conductivity of the sea water: 5
Preferably the dilution water has a conductivity reading of less than 1,000 μS/cm, preferably less than 400 μS/cm. In fact, normally a single stage of reverse osmosis is used to desalinate sea water. In other applications, normally two stages are used0 to obtain a better quality (in other words, less conductivity). In the case of reverse osmosis for sea water, the conductivity of the water product or permeated water is usually between 700-100 microsiemens/cm. This permeated water is preferably the one that will be used for diluting, although any other water source could be used. In the case of permeated water resulting from two stages of reverse osmosis, its conductivity reading is usually between 300-10 microsiemens/cm. This water could also be used advantageously as dilution water.
The aπtiscalant agent is metered to the sea water supplied to the reverse osmosis desalination plant, at the beginning. Although there are two stages, the metering is always done in the first stage.
Advantageously, the antiscalant compounds containing phosphorous comprise at least one compound from the group made up of organophosphorated compounds, polyphosphates, phosphinocarboxylic acid and mixtures thereof. Preferably these compounds are also mixed with other compounds, such as for example polycarboxylic acids and/or the salts thereof, wherein it is particularly advantageous that the polycarboxylic acid be a compound from the group made up of homopolymers derived from polyacrylic acid, polymethacrylic acid, polymaleic acid and polyaspartic acid, copolymers and terpolymers of acrylic acid, metacrylic acid, maleic acid, vinylsulphonic acid, alkylsulphonic acid, metalylsulphonic acid, 2- acrylamide-2-metyl-i-propansulphonic acid, vinylphosphonic acid and acryalamide.
Preferably the organophosphorated compounds are organophosphonated compounds, and very preferably they are phosphonic acids and the derived salts thereof (phosphonates).
It is also advantageous that the organophosphonated compounds be compounds from the group made up of phosphonocarboxylic acid, ethylendiaminotetra(methylenphosphonic) acid and the salts thereof, hexamethylendiaminotetra(methylenphosphonic) acid and the salts thereof, diethylentriaminopenta(methylenρhosphonic) acid and the salts thereof, aminotrt(methylenphosphonic) acid and the salts thereof, 1-hydroxylethyliden(1 ,1-diphosphonic) acid and the salts thereof, 2-phosphonobutane-1,2,4-tricarboxylic acid and the salts thereof, morpholinometane diphosphonic acid and the salts thereof, ethanol aminobismethylenphosphonic acid and the salts thereof, ethylentriaminopentakis(methylenphosphonic) acid and the salts thereof, bis(hexamethylen)triaminopenta-(rnethylenphosphonic) acid and the salts thereof,
(2-hydroxyethyl)iminobis-(methylenphosρhonic) acid and the salts thereof.
Preferably the dilution stage is carried out in a conditioning tank and comprises stirring performed with stirring means.
Advantageously the orthophosphate concentration analysis stage is carried out using a colorimetric method.
As already mentioned, preferably the analysis stage of the total phosphorous content comprises a substage wherein the polyphosphates and/or compounds containing organic phosphorous are hydrolysed into orthophosphates, and, advantageously, a substage wherein the orthophosphate analysis is performed using a colorimetric method.
The hydrolysis is preferably carried out using a method from the group made up of digestion with perchloric acid, oxydation with peroxodisulphate, digestion with nitric acid - sulphuric acid and oxydative degradation by ultraviolet radiation.
For its part, the cotormetric method is preferably a method from the group made up of the colorimetric method of vanadomolibdophosphoric acid, the stannous chloride method and the ascorbic acid method.
Generally, both the method for hydrolysing the polyphosphates and/or the compounds containing organic phosphorous into orthophosphates, and the above- mentioned colormetric methods are methods known to a person skilled in the art.
The aim of the invention is also a method for controlling a reverse osmosis sea water desalination plant, where the plant has means for adding antiscalant compounds containing phosphorous at a sea water inlet flow and means for regulating and controlling the addition means, characterized in that an analysis method according to the invention is performed on said salt water inlet flow and the result of said quantitative analysis is sent to said regulation and control means. In fact, the analysis method according to the invention provides obtainable results in a
very short space of time (in a few minutes), which means that a quasi continuous control can be set up, which greatly reduces the risk of scale forming on the membranes since the amount of antiscalant compounds to be added can be modified almost in real time or, where applicable, the desalination process can be interrupted.
Another aim of the invention is a piece of equipment for controlling a reverse osmosis sea water desalination plant, characterized in that it has dilution means and analysis means suitable for performing an analysis method according to the invention.
Brief description of the drawings
Other advantages and characteristics of the invention will be appreciated from the following description, wherein, a preferable embodiment of the invention is described in a non-limiting manner, with reference to the accompanying drawings, wherein:
Fig. 1 is an evolution graph, over time, of the concentration of an antiscalant compound containing phosphorous in a sea water current that supplies a reverse osmosis desalination plant, measured by means of control equipment according to the invention.
Detailed description of some embodiments of the invention
Assay in a pilot reverse osmosis plant :
The antiscalant compound is transported in concentrated format. The concentrated antiscalant compound used is a solution at 25.35% of ethylendiamine tetra(methylenphosphoήic acid) pentasodium salt. The concentrated antiscalant solution is diluted in a dilution tank before being metered continuously to the supply
water. The concentrated antiscalant solution is diluted up to a concentration of 25% with water that has a conductivity reading of 168 microsiemens/cm.
The antiscalant compound diluted in the previous stage is metered continuously at a flow rate of 0.024 millimetres per minute (mL/min) into the water supplied to the plant (which has an approximate flow rate of 4000 mUmin). The concentration of the antiscalant compound in the supply water is approximately 1.5 ppm (parts per million).
The sea water that enters the plant has a conductivity reading of 46,890 microsiemens/cm.
The metered inhibitor concentration in the sea water supplied to the osmosis plant is analysed continuously. The analysis comprises the following stages:
- Stage of diluting the sea water that contains the antiscalant compound. Sea water is pumped from the plant supply effluyent, after metering the antiscalant compound, to the sample conditioning tank. The sea water containing the antiscalant compound is metered into the conditioning tank by a pump at a flow rate of 9.7 mL/min. At the same time, dilution water is metered into the conditioning tank, said dilution water having a conductivity reading of 168 microsiemens/cm, in order to dilute the sea water containing the antiscalant compound. The dilution water is added to the conditioning tank by a metering pump operating at a rate of 29.1 mL/min. The sea water containing the antiscalant compound and the dilution water are mixed in the conditioning tank using a stirrer. The sea water containing the antiscalant compound is diluted at a dilution factor of 4. The conductivity reading of the mixture is 10,930 microsiemens/cm. The time period during which the water remains in the conditioning tank is approximately 60 minutes.
- On-line analysis of the orthophosphate concentration and of the concentration of total phosphorous in the conditioning tank water. The analysis is carried out at 10 minute intervals. A process photometer is used to carry out the analysis to
determine the total phosphorous content. The essential part of the equipment is the unit combining the digestion tub and the photometer. This unit ensures a fast, complete mixture of the sample with the digestion agent and other reagents, fast heating and cooling, and the measurements of the orthophosphate concentration .
1. In a first stage a sample is taken of the conditioning tank water and the orthophosphate content thereof is analysed. To this end, the conditioning tank water sample is fed into the digestion tub using a peristaltic pump. The ascorbic acid method is used to analyse the orthophosphate content. This method is based on the reaction of orthophosphate ions with an acid solution containing molibdate and antimonium ions to form the antimonyl- phosphomolibdate complex. The complex formed is reduced with ascorbic acid to produce a strongly coloured blue molibdene complex. The intensity of the blue colour is proportional to the orthophosphate concentration. The reagents are added to the tub containing the water sample using peristaltic pumps, the tub is shaken and when the reaction finishes the intensity of the blue colouring is measured, taking -into account the zero that has been determined shortly before, and which is considered as a measurement of the phosphate concentration expressed in milligrams per litre of phosphorous (mg/L P).
2. In a second stage a sample is taken of the conditioning tank water and the total phosphorous content is analysed. To this end, the conditioning tank water sample is fed into the digestion tub using a peristaltic pump. In a first stage the polyphosphates and organophosphorated compounds and phosphinocarboxylic acids of the sample are hydrolyzed into orthophosphates via digestion by boiling in a strong acid solution. This is achieved by oxydating the phosphorous compounds with sodium peroxodisulphate in a strong acid solution. The sample is boiled and excess pressure is applied thereto to accelerate the process and this way, short digestion times are achieved. Then the orthophosphate analysis is carried out in the same tub. The ascorbic acid method is used, as explained above. The orthophosphate assessed this way is a
measurement of the concentration of total phosphorous expressed in milligrams per litre of phosphorous (mg/L P).
- Calculations to determine the concentration of antiscalant compound, corresponding in the example to the concentration of the solution at 25.35% ethylendiamine tetra(methylenphosphonic acid) pentasodium salt. The formula used to calculate the antiscalant concentration is as follows:
ConC = ((Pτotal — > o-phospbate) fd)/faπtlsealaπt compound)
Where:
Cone: concentration of the solution at 25.35% of ethylendiamine tetra(methylenphosphonic acid) pentasodium salt in the water supplied to the pilot reverse osmosis plant, expressed in mg/L of antiscalant compound.
Pτotah concentration of total phosphorous analysed in the supply water, expressed in mg/L of phosphorous.
Po-phosphat«: concentration of orthophosphate analysed in the supply water, expressed in mg/L of phosphorous. fd: dilution of the sea water containing antiscalant compounds, which is performed in the conditioning tank. In the example, dilution 4 was performed.
Fantiscaiant compound: specific constant for each antiscalant compound. In the example, the value of this factor is 0.057516
- The results obtained in the example are shown in Figure 1. The abscissas axis represents the time expressed in minutes, and the ordenate axis represents the antiscalant compound concentration (solution at 25.35% of ethylendiamine tetra(methylenphosphonic acid) pentasodium salt) in the water supplied to the pilot reverse osmosis plant. The average antiscalant concentration during the assay period was 1.549 mg/L. The desired antiscalant concentration in the supply water was 1.5 mg/L. A very exact reading of the antiscalant concentration
was obtained. The standard deviation of the concentrations measured was 1.229 % with respect to the average.
Both in this description and in the claims, it is indicated that the analysis method comprises two stages: the stage of analysing the orthophosphate concentration contained in the diluted water (called stage [b]), and stage of analysing the total phosphorous content contained in the diluted water (called stage [c]). It must be made clear that the method must comprise both stages, but the order thereof is irrelevant. Therefore, it must not be understood that one of the stages must be performed necessarily before the other. Instead, to the contrary, the order in which both stages is performed is completely irrelevant.
Claims
1 - On-line quantitative analysis method of the content of antiscalant compounds containing phosphorous in a reverse osmosis sea water desalination plant, characterized in that it comprises the following stages:
[a] dilution of sea water with dilution water to obtain diluted water, until the diluted water has a conductivity reading of between 25,000 and 3,000 microsiemeπs/cm,
[b] analysis of the orthophosphate concentration contained in the diluted water,
[c] analysis of the total concentration of phosphorous contained in the diluted water,
[d] determination of the concentation of said antiscalant compounds in the sea water, taking into account the difference between the total phosphorous and the orthophosphate, multiplying by a specific factor of the antiscalant compounds and multiplying by a factor related with the dilution.
2 - Method according to claim 1, characterized in that said dilution water has a conductivity reading of less than 1000 μS/cm, preferably less than 400 μS/cm.
3 - Method according to one of the claims 1 or 2, characterized in that said antiscalant compounds containing phosphorous comprise at least one compound from the group made up of organophosphorated compounds, polyphosphates, phosphinocarboxylic acid and mixtures thereof.
4 - Method according to claim 3, characterized in that said organophosphorated compounds are organophosphonated compounds, preferably phosphonic acids or the salts derived therefrom.
5 - Method according to claim 4, characterized in that said organophosphonated compounds are compounds from the group made up of:
phosphonocarboxylic acid, ethylendiaminotetra(methylenphosphonic) acid and the salts thereof, hexamethylendiaminotetra(methylenphosphonic) acid and the salts thereof, diethylentriaminopenta(methylenphosphonic) acid and the salts thereof, aminotri(methylenphosphonic) acid and the salts thereof,
1-hydroxylethyliden(1,1-diphosphonic) acid and the salts thereof, 2-phosphonobutane-1,2,4-tricarboxylic acid and the salts thereof, morpholinometane diphosphonic acid and the salts thereof, ethanol aminobismethylenphosphonic acid and the salts thereof, ethylentriaminopentakis(methylenphosphonic) acid and the salts thereof, bis(hexamethylen)triaminopenta-(methylenphosphonic) acid and the salts thereof, (2-hydroxyethyl)iminobis-(methylenphosphonic) acid and the salts thereof
6 - Method according to any of the claims 3 to 5, characterized in that said antiscalant compouns comprise, in addition, at least one carboxylic acid.
7 - Method according to claim 6, characterized in that said polycarboxylic acid is a compound in the group made up of homopolymers derived from polyacrylic acid, polymetacrylic acid, polymaleic acid and polyaspartic acid, copolymers and terpolymers of acrylic acid, metacryϋc acid, maleico acid, vinylsulphonic acid, alkyl sulphonic acid, metalyl sulphonic acid, 2-acrylamide-2-metyl-1-propansulphonic acid, vinyl phosphonic acid and acryalamide.
8 - Method according to any of the claims 1 to 7, characterized in that said dilution stage is carried in a conditioning tank and comprises stirring performed with stirring means.
9 - Method according to any of the claims 1 to 8, characterized in that said stage of analysing the orthophosphate concentration is performed using a colorimetric method.
10 - Method according to any of the claims 1 to 9, characterized in that said stage of analysing the total phosphorous content comprises a substage wherein the
polyphosphates and/or compounds containing organic phosphorous and hydrolysed into orthophosphates, and a substage wherein orthophosphates are analysed using a colormetric method.
11 - Method according to claim 10, characterized in that said hydrolysis is performed by a method from the group made up of digestion with perchloric acid, oxidation with peroxodisulphate, digestion with nitric acid - sulphuric acid oxydative degradation by ultraviolet radiation.
12 - Method according to any of the claims 9 to 11, characterized in that said colorimetric method is a method from the group made up of colorimetric method of vanadomolibdophosphoric acid, stannous chloride method and ascorbic acid method.
13 - Method according to any of the claims 1 to 12, characterized in that said dilution is performed by applying a dilution factor that is variable according to the conductivity of the sea water, such that if said conductivity is less than 35,000 microsiemens/cm, said dilution factor is 3, if said conductivity is between 35,000 and 47,000 microsiemens/cm, said dilution factor is 4, if said conductivity is between 47,001 and 55,000 microsiemens/cm, said dilution factor is 5, and if said conductivity is greater than 55,000 microsiemens/cm, said dilution factor is 6.
14 - Method for controlling a reverse osmosis sea water desalination plant, where said plant has means for adding antiscalant compounds containing phosphorosous at a sea water inlet flow and means for regulating and controlling said addition means, characterized in that an analysis method is carried out according to any of the claims 1 to 13 at said sea water inlet flow and the result of said quantitative analysis is transmitted to said regulating and control means .
15 - Equipment for controlling a reverse osmosis sea water desalination plant, characterized in that it has dilution means and analysis means suitable for carrying out an analysis method according to any of the 1 to 13.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP200801223 | 2008-04-29 | ||
ES200801223A ES2303810B1 (en) | 2008-04-29 | 2008-04-29 | ONLINE QUANTITATIVE ANALYSIS PROCEDURE FOR THE CONTENT OF ANTI-INCRUSTANT COMPOUNDS CONTAINING MARINE WATER PHOSPHORY IN A REVERSE DESALINIZING INSTALLATION P0R AND CORRESPONDING CONTROL PROCEDURE AND CONTROL EQUIPMENT. |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009132727A1 true WO2009132727A1 (en) | 2009-11-05 |
Family
ID=39669781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2009/001406 WO2009132727A1 (en) | 2008-04-29 | 2009-02-27 | On-line quantitative analysis method of the content of antiscalant compounds containing phosphorous in sea water in a reverse osmosis desalination plant and corresponding control method and equipment |
Country Status (2)
Country | Link |
---|---|
ES (1) | ES2303810B1 (en) |
WO (1) | WO2009132727A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2648351C1 (en) * | 2017-06-08 | 2018-03-23 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский химико-технологический университет имени Д.И. Менделеева" (РХТУ им. Д.И. Менделеева) | Method of determination of the effective concentration of antiscalant for suppression of crystallization of sparingly soluble salts in water |
IT201600122231A1 (en) * | 2016-12-01 | 2018-06-01 | Lw S R L | METHOD FOR MEASURING THE CONCENTRATION OF AN ANTI-DIRTY ADDITIVE IN A CIRCULATING SALINE WATER FLOW IN A DESALINIZATION PLANT AND RELATED APPLICATIONS. |
FR3074490A1 (en) * | 2017-12-06 | 2019-06-07 | Chemdoc | DEVICE FOR DEMINERALIZING PURELY WATER OR SEA WATER |
CN112047498A (en) * | 2020-07-29 | 2020-12-08 | 深圳市长隆科技有限公司 | Circulating water phosphorus-free corrosion and scale inhibitor and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270216A (en) * | 1992-02-13 | 1993-12-14 | Gas Research Institute | Measurement of low phosphonate concentrations |
WO1994000595A1 (en) * | 1992-06-25 | 1994-01-06 | Diversey Corporation | Phosphate analysis |
US6177276B1 (en) * | 1997-12-16 | 2001-01-23 | Chemtreat, Inc. | Oxidation and measurement of phosphonates in aqueous solutions |
WO2006128730A1 (en) * | 2005-06-02 | 2006-12-07 | Toray Membrane Europe Ag | Improved process for treating an aqueous medium using reverse osmosis and reverse osmosis system therefor |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2291133B1 (en) * | 2006-08-10 | 2008-12-16 | Acciona Agua, S.A.U. | PROCEDURE FOR THE ELIMINATION OF SEA WATER BORUS BY REVERSE OSMOSIS MEMBRANES. |
-
2008
- 2008-04-29 ES ES200801223A patent/ES2303810B1/en active Active
-
2009
- 2009-02-27 WO PCT/EP2009/001406 patent/WO2009132727A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270216A (en) * | 1992-02-13 | 1993-12-14 | Gas Research Institute | Measurement of low phosphonate concentrations |
WO1994000595A1 (en) * | 1992-06-25 | 1994-01-06 | Diversey Corporation | Phosphate analysis |
US6177276B1 (en) * | 1997-12-16 | 2001-01-23 | Chemtreat, Inc. | Oxidation and measurement of phosphonates in aqueous solutions |
WO2006128730A1 (en) * | 2005-06-02 | 2006-12-07 | Toray Membrane Europe Ag | Improved process for treating an aqueous medium using reverse osmosis and reverse osmosis system therefor |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201600122231A1 (en) * | 2016-12-01 | 2018-06-01 | Lw S R L | METHOD FOR MEASURING THE CONCENTRATION OF AN ANTI-DIRTY ADDITIVE IN A CIRCULATING SALINE WATER FLOW IN A DESALINIZATION PLANT AND RELATED APPLICATIONS. |
WO2018100505A1 (en) * | 2016-12-01 | 2018-06-07 | Lw S.R.L. | Method for measuring the concentration of an anti- fouling additive in a flow of saline water circulating in a desalination plant and applications thereof |
EP3548438B1 (en) * | 2016-12-01 | 2021-12-22 | LW S.r.l. | Method for measuring the concentration of an anti- fouling additive in a flow of saline water circulating in a desalination plant and applications thereof |
RU2648351C1 (en) * | 2017-06-08 | 2018-03-23 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Российский химико-технологический университет имени Д.И. Менделеева" (РХТУ им. Д.И. Менделеева) | Method of determination of the effective concentration of antiscalant for suppression of crystallization of sparingly soluble salts in water |
FR3074490A1 (en) * | 2017-12-06 | 2019-06-07 | Chemdoc | DEVICE FOR DEMINERALIZING PURELY WATER OR SEA WATER |
CN112047498A (en) * | 2020-07-29 | 2020-12-08 | 深圳市长隆科技有限公司 | Circulating water phosphorus-free corrosion and scale inhibitor and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
ES2303810A1 (en) | 2008-08-16 |
ES2303810B1 (en) | 2009-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2722312B1 (en) | Method of inhibiting corrosion and deposition in desalination systems | |
US7595000B2 (en) | Operation of evaporative cooling towers with minimal or no blowdown | |
Shih et al. | Ranking of antiscalant performance for gypsum scale suppression in the presence of residual aluminum | |
SE519742C2 (en) | Deposition and / or corrosion inhibiting composition and method of inhibition | |
WO2009055377A1 (en) | Method of inhibiting scale formation and deposition in desalination systems | |
TW200538697A (en) | Control of cooling water system using rate of consumption of fluorescent polymer | |
EP2754644A1 (en) | Evaporative recirculation cooling water system, method of operating an evaporative recirculation cooling water system and a method of operating a water deionizing system | |
JPH0994598A (en) | Corrosionproof and scale-proof method of open circulating cooling water system | |
CA2403274C (en) | Use of control matrix for cooling water systems control | |
US10287199B2 (en) | Use of phosphotartaric acid and the salts thereof for the treatment of water in water-conducting systems | |
AU2001253081A1 (en) | Use of control matrix for cooling water systems control | |
WO2009132727A1 (en) | On-line quantitative analysis method of the content of antiscalant compounds containing phosphorous in sea water in a reverse osmosis desalination plant and corresponding control method and equipment | |
Greenlee et al. | Effect of antiscalant degradation on salt precipitation and solid/liquid separation of RO concentrate | |
Mangal et al. | Role of phosphate and humic substances in controlling calcium carbonate scaling in a groundwater reverse osmosis system | |
TW201019058A (en) | Proactive control system for an industrial water system | |
JPH05230676A (en) | Synergistic combination of sodium silicate and orthophosphate for inhibiting corrosion of carbon steel | |
Andrews et al. | Effective scale control for seawater RO operating with high feed water pH and temperature | |
TWI703093B (en) | Processing method and processing device of ammonia-containing discharged water | |
Demadis et al. | Chemistry of Organophosphonate Scale Growth lnhibitors: 3. Physicochemical Aspects of 2‐Phosphonobutane‐1, 2, 4‐Tricarboxylate (PBTC) And Its Effect on CaCO3 Crystal Growth | |
JP2006142301A (en) | Method and equipment for treating phosphorus-containing water | |
Oshchepkov et al. | Mechanisms of scale inhibition derived from a fluorescent-tagged antiscalant visualization | |
Zach-Maor et al. | Diagnostic analysis of RO desalting treated wastewater | |
WO2015119528A1 (en) | Inhibitor of metal corrosion and scaling | |
JP2000516141A (en) | Method for suppressing scale formation using ether-1,1-diphosphonate | |
KR101765356B1 (en) | Method for the Removing and Reducing Scaling |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09737771 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09737771 Country of ref document: EP Kind code of ref document: A1 |